4 Analysts Have This to Say About Chimerix
Portfolio Pulse from Benzinga Insights
In the last quarter, Chimerix (NASDAQ:CMRX) received 4 bullish ratings from analysts, with an average 12-month price target of $8.75, a decrease of 20.45% from the previous average price target of $11.00.
August 17, 2023 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Chimerix received 4 bullish ratings from analysts in the last quarter, with a decreased average 12-month price target.
The news is directly about Chimerix and its analyst ratings. The decrease in the average price target might indicate a potential decrease in the stock price, but the bullish ratings from analysts could balance this out, leading to a neutral short term impact.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100